Utreloxastat
Utreloxastat (PTC857) is a novel 15-lipoxygenase inhibitor that can be used to study amyotrophic lateral sclerosis .
Product Specifications
CAS Number
1213269-96-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
276.41
Molecular Formula
C18H28O2
Notes
Research use only, not for human use.
Receptor
Lipoxygenase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog